College of American Pathologists (CAP)

New Research Defines Intrauterine Placental Transmission of COVID-19 From Pregnant Women to the Fetus

30-Jul-2020 2:05 PM EDT, by College of American Pathologists (CAP)

Newswise — NORTHFIELD, Ill. (July 29, 2020)—Reports of increasing numbers of pregnant women with COVID-19 show that most neonates (newborn infants) are uninfected by the new coronavirus, SARS-CoV-2. However, a very small number of neonates have tested positive for COVID-19. This has led investigators to examine whether mother-to-infant (vertical) transmission occurs and, if it does, whether it develops in the uterus prior to delivery, and how it happens in a new research article published in the Archives of Pathology & Laboratory Medicine (ARCHIVES).

“Evaluating placentas from neonates with COVID-19 is instrumental in determining the potential role and significance of transplacental transmission of the coronavirus,” said David A. Schwartz, MD, FCAP, a specialist in placental pathology and medical epidemiology as well as global maternal health and the lead author of the study. According to Dr. Schwartz, results from recent studies suggest that in rare instances, transplacental transmission of the coronavirus is occurring.

In their research, Dr. Schwartz and his co-authors provide guidance and photographic illustrations demonstrating criteria for the diagnosis of intrauterine placental infection and fetal transmission with coronavirus occurring before birth. In order to determine the occurrence of prenatal transplacental infection, the authors recommend that health care professionals involved with obstetric care consider saving and testing select placentas using either antibody staining (immunohistochemistry) for SARS-CoV-2, or that identification of the viral nucleic acid be performed using in situ RNA hybridization or RNAscope methods. The study authors believe that positive staining of fetal cells using either of these techniques in placentas from neonates testing positive for COVID-19 is indicative of transplacental transmission of the infection. They also provide clinical criteria for diagnosis of early neonatal COVID-19 infections.

This new research—an international collaboration by Drs. Schwartz, Babak Beigi, Fereshteh Moshfegh, Nazanin Zafaranloo, Luisa Patanè, and Denise Morotti—expands the body of science available on the transmission of SARS-CoV-2 between mother, the placenta and infant, and recognizes a recent Italian study that demonstrates the virus pathologically in specific fetal cells of the placenta (trophoblast) from two infected newborn infants, indicating infection of fetal tissues before delivery. The largest of fetal organs, the placenta has been important for understanding mechanisms of transmission of several different viruses from pregnant women to the fetus including HIV, Ebola and Zika viruses (the latter virus was previously identified in the placenta from an infected fetus with the congenital Zika syndrome by Dr. Schwartz).

“Identification of the virus in fetal cells of the placenta provides strong evidence of intrauterine fetal infection. Even though the relative risks and proportions of neonatal infection remain unknown, identifying the mechanisms of viral transmission can help guide management of pregnant women with COVID-19 and neonates,” said Dr. Schwartz. “From a clinical perspective, identifying viral transmission mechanisms can help in making decisions regarding need for cesarean sections, isolation of neonates, breast feeding and other factors.”

Pathologists are medical doctors who are critical members of the health care team, combining a scientist’s understanding of what laboratory evidence suggests and a specialty physician’s knowledge of medicine to determine the correct diagnosis. As the international health emergency continues to evolve, the public should follow the Centers for Disease Control and Prevention’s (CDC) recommendations for prevention and treatment of the COVID-19 disease.


Published since 1926, Archives of Pathology & Laboratory Medicine (ARCHIVES) is the monthly international peer-reviewed journal of the College of American Pathologists. It was voted in 2009 the only pathology journal among the top 100 most influential journals of the past 100 years by the BioMedical and Life Sciences Division of the Special Libraries Association.

About the College of American Pathologists

As the world’s largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists serves patients, pathologists, and the public by fostering and advocating excellence in the practice in the practice of pathology and laboratory medicine worldwide. For more information, read the CAP Annual Report at CAP.ORG.

Filters close

Showing results

110 of 2927
Released: 14-Aug-2020 4:55 PM EDT
Managing your child’s diabetes during COVID-19
University of Texas Health Science Center at Houston

These days it’s hard not to worry about whether a quick outing to the grocery store will result in catching COVID-19. But for parents with children who have preexisting health conditions such as diabetes, it can be especially hard not to worry about whether their child is at a higher risk of becoming severely ill from the virus.

Newswise: 1200x800?cb=1597350935
Released: 14-Aug-2020 3:35 PM EDT
Gaiters do no harm: WVU toxicologists find coverings help contain the spread of exhaled droplets
West Virginia University

Experts with the West Virginia University Center for Inhalation Toxicology found that – assuming it’s a good fit - a gaiter will, despite recent reports, provide a respiratory containment of exhaled droplets comparable to a common over-the-ear cloth mask.

Newswise: AI software enables real-time 3D printing quality assessment
Released: 14-Aug-2020 3:05 PM EDT
AI software enables real-time 3D printing quality assessment
Oak Ridge National Laboratory

Oak Ridge National Laboratory researchers have developed artificial intelligence software for powder bed 3D printers that assesses the quality of parts in real time, without the need for expensive characterization equipment.

Newswise: Is the COVID-19 virus pathogenic because it depletes specific host microRNAs?
Released: 14-Aug-2020 3:05 PM EDT
Is the COVID-19 virus pathogenic because it depletes specific host microRNAs?
University of Alabama at Birmingham

Why is the COVID-19 virus deadly, compared to cold-causing coronaviruses? Analysis current literature and bioinformatic study of seven coronaviruses, suggests that SARS-CoV-2 acts as a microRNA “sponge,” leading to better viral replication and blockage of the host immune response.

Released: 14-Aug-2020 2:30 PM EDT
UW team developing model to help lower COVID-19 infections in Seattle, other major cities
University of Washington

A UW team has received a grant to develop a model that uses local data to generate policy recommendations that could help lower COVID-19 infections in King County, which includes Seattle.

Newswise: Cardiovascular risk factors tied to COVID-19 complications and death
12-Aug-2020 7:05 PM EDT
Cardiovascular risk factors tied to COVID-19 complications and death

COVID-19 patients with cardiovascular comorbidities or risk factors are more likely to develop cardiovascular complications while hospitalized, and more likely to die from COVID-19 infection, according to a new study published August 14, 2020 in the open-access journal PLOS ONE by Jolanda Sabatino of Universita degli Studi Magna Graecia di Catanzaro, Italy, and colleagues.

Newswise: Study shows frequently used serology test may not detect antibodies that could confirm protection against reinfection of COVID-19
Released: 14-Aug-2020 1:55 PM EDT
Study shows frequently used serology test may not detect antibodies that could confirm protection against reinfection of COVID-19
University of Texas M. D. Anderson Cancer Center

Two different types of detectable antibody responses in SARS-CoV-2 (COVID-19) tell very different stories and may indicate ways to enhance public health efforts against the disease, according to researchers at The University of Texas MD Anderson Cancer Center. Antibodies to the SARS-CoV-2 spike protein receptor binding domain (S-RBD) are speculated to neutralize virus infection, while the SARS-CoV-2 nucleocapsid protein (N-protein) antibody may often only indicate exposure to the virus, not protections against reinfection.

Released: 14-Aug-2020 1:50 PM EDT
USC scientists identify the order of COVID-19's symptoms
University of Southern California (USC)

USC researchers have found the likely order in which COVID-19 symptoms first appear: fever, cough, muscle pain, and then nausea, and/or vomiting, and diarrhea.

Released: 14-Aug-2020 1:45 PM EDT
Stay the Course with Personal Finances during Pandemic, Johns Hopkins Expert Advises
Johns Hopkins University Carey Business School

Keeping on a careful and steady path is the wisest approach to personal money management during the uncertainties of the COVID-19 crisis, says Associate Professor Yuval Bar-Or of the Johns Hopkins Carey Business School.

access_time Embargo lifts in 2 days
Embargo will expire: 17-Aug-2020 11:00 AM EDT Released to reporters: 14-Aug-2020 1:25 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 17-Aug-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Showing results

110 of 2927